Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Bionano Genomics, Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
BNGO · Nasdaq · Healthcare · Medical Instruments and Supplies
$1.01+0.5%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 10, 2026
Company outlook: revenue of $31M to $33M for Fiscal year 2026 — up 12.2% on a year earlier, slower than the 21.4% just reported